Status epilepticus: Updates on mechanisms and treatments

Area of Science:

• Neuroscience
• Neurology
• Cellular Biology

Background:

• Status epilepticus (SE) is a critical neurological emergency characterized by prolonged seizures, leading to respiratory compromise and neuronal damage.
• Untreated SE can progress to benzodiazepine resistance, establishing refractory and super-refractory states.
• SE involves altered GABAergic and glutamatergic neurotransmission, increasing neuronal activity and seizure network expansion.

Purpose of the Study:

• To review molecular mechanisms, including synaptic transmission changes and energy metabolism, underlying SE.
• To examine clinical studies on benzodiazepine and anticonvulsant efficacy in SE treatment.
• To summarize current SE management strategies and explore future therapeutic avenues.

Main Methods:

• Review of experimental animal studies on GABA-A, NMDA, and AMPA receptor function during SE.
• Analysis of clinical research evaluating anticonvulsant treatments in prehospital and in-hospital settings.
• Synthesis of data on neuronal energy consumption and plasticity in SE.

Main Results:

• SE is associated with impaired GABAergic inhibition and enhanced glutamatergic neurotransmission.
• Neuronal adaptation involves utilizing alternative energy sources to meet heightened metabolic demands.
• Clinical studies highlight varying efficacy of current treatments, necessitating further research.

Conclusions:

• Understanding SE's molecular underpinnings is key to developing effective treatments.
• Current therapeutic options for SE have limitations, particularly in refractory cases.
• Ongoing research and exploration of novel anticonvulsant agents are vital for improving SE outcomes.